WIB22: She re­shaped mi­graine sci­ence and led key tri­als for new drugs, but Sheena Au­ro­ra isn’t done

This pro­file is part of End­points News’ 2022 spe­cial re­port about Women in Bio­phar­ma R&D. You can read the full re­port here.

For decades — even cen­turies — mi­graines were con­sid­ered a dis­or­der suf­fered by hys­ter­i­cal women.

Even when the fa­ther of mod­ern-day mi­graine re­search pi­o­neered a new un­der­stand­ing of mi­graine as a bi­o­log­i­cal phe­nom­e­non hav­ing to do with blood ves­sels, he fo­cused on ex­plain­ing the con­di­tion for men but de­scribed women mi­graine suf­fer­ers, who make up the vast ma­jor­i­ty of the pa­tient pop­u­la­tion, as in­ad­e­quate wives and moth­ers.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN